Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has informed BSE that Mrs. Brij Bala Gupta, a Director on the Board, resigned effective 25 November 2025, citing pre-occupation and certain unavoidable circumstances. She was not a member of any board committee. The filing itself is a follow-up to an earlier announcement — the company says it had unintentionally omitted the resignation letter then and is now attaching it along with detailed reasons, as required by SEBI's disclosure norms. The director has confirmed there are no other material reasons behind her exit. No replacement appointment is mentioned in this filing.
A single non-executive director stepping down for personal reasons is a routine board-level change. It is unlikely to materially affect operations or the stock price, though frequent or unexplained board exits can be a mild governance red flag for investors to watch over time.